BioLife4D Corporation (SAVU)

BioLife4D will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$5.20 - $7.20

Shares Offered

1,596,154

Deal Size

$9.90M

BioLife4D Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020
Net Income	-1.5	-1.7
Depreciation & Amortization	0.01	0.01
Share-Based Compensation	0.63	0.21
Other Operating Activities	-0.26	0.02
Operating Cash Flow	-1.12	-1.46
Capital Expenditures	-	-0.01
Investing Cash Flow	-	-0.01
Share Issuance / Repurchase	1.57	0.57
Debt Issued / Paid	0.17	-0.03
Other Financing Activities	-0.03	-0.08
Financing Cash Flow	1.72	0.46
Net Cash Flow	0.6	-1
Free Cash Flow	-1.12	-1.47

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).